FDA Health Law Policy Human Subjects Research Patient Care Pharmaceuticals Public Health Scientific Evidence Vaccines
patents
-
-
Contributors FDA Health Law Policy Human Subjects Research Intellectual Property Jacob Sherkow Nicholson Price Patient Care Pharmaceuticals Public Health Rachel Sachs Scientific Evidence VaccinesHow are COVID-19 Vaccine Manufacturers Building Trust in the FDA’s Approval Process?
Read more: How are COVID-19 Vaccine Manufacturers Building Trust in the FDA’s Approval Process? -
Compulsory Licensing for Pharmaceuticals in the EU: A Reality Check
Read more: Compulsory Licensing for Pharmaceuticals in the EU: A Reality Check -
Biotechnology Featured Health Law Policy Intellectual Property Jorge Contreras Public Health VaccinesDeconstructing Moderna’s COVID-19 Patent Pledge
Read more: Deconstructing Moderna’s COVID-19 Patent Pledge -
Contributors FDA Health Law Policy Human Subjects Research Intellectual Property Jacob Sherkow Nicholson Price Patient Care Pharmaceuticals Public Health Rachel Sachs Scientific Evidence VaccinesHow Does Moderna’s COVID-19 Vaccine Work, and Who Is Funding Its Development?
Read more: How Does Moderna’s COVID-19 Vaccine Work, and Who Is Funding Its Development? -
Contributors FDA Health Law Policy Human Subjects Research Intellectual Property Jacob Sherkow Nicholson Price Patient Care Pharmaceuticals Public Health Rachel Sachs Scientific Evidence VaccinesCOVID-19 Vaccine Advance Purchases Explained
Read more: COVID-19 Vaccine Advance Purchases Explained -
Antitrust Beatrice Brown Bioethics Empirical Generic Drugs Health Care Reform Health Law Policy Intellectual Property Pharmaceuticals Public HealthTo Cut Prescription Drug Spending, Stop Delays for Generic Competition
Read more: To Cut Prescription Drug Spending, Stop Delays for Generic Competition -
Biotechnology FDA Featured Health Law Policy Intellectual Property Jorge Contreras Medical devices Public HealthPatent Fakes: How Fraudulent Inventions Threaten Public Health, Innovation, and the Economy
Read more: Patent Fakes: How Fraudulent Inventions Threaten Public Health, Innovation, and the Economy -
Opportunities and challenges for user-generated licensing models in gene-editing
Read more: Opportunities and challenges for user-generated licensing models in gene-editing -
Will the EPO’s Enlarged Board of Appeal step into the CRISPR patent battle?
Read more: Will the EPO’s Enlarged Board of Appeal step into the CRISPR patent battle?